| 9.13 Data as of May 22 |  -0.10 / -1.08%Today’s Change | 4.79 Today|||52-Week Range 9.39 | +59.34% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $14.3B |
Company Description
Boston Scientific Corp. develops, manufactures and markets medical devices that are used in a broad range of interventional medical specialties. The company's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. It operates its business through four geographic reportable segments: United States; EMEA, consisting of Europe, the Middle East and Africa; Japan and Inter-Continental, consisting of Asia Pacific and the Americas operating segments. The reportable segments represent an aggregate of all operating divisions within each segment. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Natick, MA.
Employees
Shareholders
| Mutual fund holders | 49.67% |
| Other institutional | 38.10% |
| Individual stakeholders | 1.26% |
Top Executives
| Peter Michael Nicholas, MBA | Chairman |
| Michael F. Mahoney, MBA | President, Chief Executive Officer & Director |
| Kenneth J. Pucel | EVP-Global Operations, Quality & Technology |
| Jeffrey D. Capello, MBA, CPA | Chief Financial Officer & Executive Vice President |
| Keith D. Dawkins, MD | Global Chief Medical Officer & Executive VP |
.
